Alnylam Pharmaceuticals Overview
Alnylam Pharmaceuticals Target Price
Analysts' 12-month price predictions for ALNY.
Get informed when a big investor buys or sells
+ FollowShare Price
$291.37
Average Target Price
$408.50
40.2% upside
40.2% upside2 analysts in the last 4 months
High: $447 | Low: $370
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-01 | Morgan Stanley | $370 | 27% upside |  |
| 2026-05-01 | Bernstein | $447 | 53.4% upside | |
| 2026-02-17 | Canaccord Genuity | $429 | 47.2% upside | |
| 2026-02-13 | Morgan Stanley | $360 | 23.6% upside | |
| 2026-02-13 | Bernstein | $451 | 54.8% upside | |
| 2026-02-13 | Chardan Capital | $425 | 45.9% upside | |
| 2026-02-12 | Stifel NicolausPaul Matteis | $444 | 52.4% upside | |
| 2026-01-30 | H.C. Wainwright | $510 | 75% upside | |
| 2026-01-20 | RBC Capital | $465 | 59.6% upside | |
| 2026-01-20 | Wells Fargo | $376 | 29% upside | |
| 2026-01-12 | Needham | $529 | 81.6% upside | |
| 2026-01-12 | Raymond JamesMartin Auster | $472 | 62% upside | |
| 2026-01-08 | Truist Financial | $530 | 81.9% upside | |
| 2026-01-06 | Bernstein | $491 | 68.5% upside | |
| 2025-12-15 | Leerink PartnersMani Foroohar | $351 | 20.5% upside | |
| 2025-12-11 | Stifel Nicolaus | $508 | 74.3% upside | |
| 2025-11-04 | H.C. WainwrightPatrick Trucchio | $570 | 95.6% upside | |
| 2025-10-31 | Barclays | $527 | 80.9% upside | |
| 2025-10-31 | OppenheimerLeland Gershell | $500 | 71.6% upside | |
| 2025-10-31 | Chardan CapitalKeay Nakae | $475 | 63% upside | |
| 2025-10-30 | UBS | $549 | 88.4% upside | |
| 2025-10-30 | Morgan StanleyMichael Ulz | $495 | 69.9% upside | |
| 2025-10-22 | Cantor Fitzgerald | $450 | 54.4% upside | |
| 2025-10-17 | Truist Financial | $535 | 83.6% upside | |
| 2025-10-06 | Morgan StanleyMichael Ulz | $475 | 63% upside | |
| 2025-10-06 | Stifel NicolausPaul Matteis | $495 | 69.9% upside | |
| 2025-09-05 | BMO CapitalKostas Biliouris | $470 | 61.3% upside | |
| 2025-07-29 | Raymond James | $370 | 27% upside | |
| 2025-07-21 | Truist FinancialDanielle Brill | $385 | 32.1% upside | |
| 2025-06-24 | BMO CapitalKostas Biliouris | $360 | 23.6% upside | |
| 2025-03-21 | Scotiabank | $338 | 16% upside | |
| 2025-01-07 | BernsteinWilliam Pickering | $310 | 6.4% upside | |
| 2024-10-24 | Canaccord GenuityWhitney Ijem | $336 | 15.3% upside | |
| 2024-10-01 | Canaccord GenuityWhitney Ijem | $366 | 25.6% upside | |
| 2024-09-27 | Bank of America SecuritiesTazeen Ahmad | $307 | 5.4% upside | |
| 2024-08-27 | BMO CapitalKostas Biliouris | $300 | 3% upside | |
| 2024-08-26 | RBC CapitalLuca Issi | $300 | 3% upside | |
| 2024-08-16 | Goldman SachsSalveen Richter | $370 | 27% upside | |
| 2024-07-08 | Canaccord GenuityWhitney Ijem | $357 | 22.5% upside | |
| 2024-06-28 | UBSEsther Rajavelu | $288 |  1.2% downside | |
| 2024-06-27 | RBC CapitalLuca Issi | $265 | 9.1% downside | |
| 2024-06-27 | Stifel NicolausPaul Matteis | $295 | 1.2% upside | |
| 2024-06-25 | Evercore ISILiisa Bayko | $260 | 10.8% downside | |
| 2024-06-25 | RBC CapitalLuca Issi | $250 | 14.2% downside | |
| 2024-06-24 | Morgan StanleyAndrew Galler | $250 | 14.2% downside | |
| 2024-06-24 | H.C. WainwrightPatrick Trucchio | $400 | 37.3% upside | |
| 2024-06-24 | Stifel NicolausPaul Matteis | $247 | 15.2% downside | |
| 2024-06-12 | RBC CapitalLuca Issi | $235 | 19.3% downside | |
| 2024-04-08 | BMO CapitalKostas Biliouris | $234 | 19.7% downside | |
| 2022-12-15 | Piper SandlerEdward Tenthoff | $253 | 13.2% downside | |